| ClinicalTrials.gov Identifier: |
NCT00467025 |
| Brief Title: |
AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib |
|
|
First Submitted : |
April 26, 2007 |
|
First Submitted that Met QC Criteria : |
April 26, 2007 |
|
First Posted : |
April 27, 2007
(Estimate)
|
|
|
Certification/Extension First Submitted : |
April 6, 2015 |
|
Certification/Extension First Submitted that Met QC Criteria : |
April 6, 2015 |
|
Certification/Extension First Posted : |
April 27, 2015
(Estimate)
|
|
|
Last Update Submitted that Met QC Criteria : |
February 23, 2016 |
|
Last Update Posted : |
March 23, 2016
(Estimate)
|
|
